subject: MESH:C000626862

object_name: childhood bladder carcinoma


subject: MESH:C000626862

subject_name: D-methadone

object_name: colon carcinoma

tested_intervention: unsure


subject: MESH:C000626862

object_name: colorectal cancer


subject: MESH:C000626862

object_name: colon cancer


subject: MESH:C000626862

object_name: ocular cancer


subject: MESH:C000626862

object_name: central nervous system cancer


subject: MESH:C000626862

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:151315

subject_name: Heparin

object_name: pneumonia


subject: CHEBI:151315

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:230519

subject_name: heparin sodium


subject: CHEBI:230519


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: Android obesity


subject: UMLS:C1313807


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: cardiac conduction defect


subject: UNII:2XLN4Y044H

object_name: Left Ventricular Systolic Dysfunction, CTCAE 3.0


subject: UNII:2XLN4Y044H

object_name: Left Ventricular Systolic Dysfunction, CTCAE 5.0


subject: UNII:2XLN4Y044H

object_name: Left ventricular systolic dysfunction


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: CHEBI:9654

subject_name: Trazodone

object_name: Sleep Apnea, CTCAE

tested_intervention: yes


subject: GTOPDB:7750

subject_name: amatuximab

object_name: Mesothelioma


subject: GTOPDB:7750

object_name: mesothelial neoplasm


subject: GTOPDB:7750

object_name: malignant mesothelioma


subject: GTOPDB:7750

object_name: non-small cell lung carcinoma


subject: GTOPDB:7750

object_name: pancreatic neoplasm


subject: GTOPDB:7750

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:7750

object_name: malignant pancreatic neoplasm


subject: GTOPDB:7750

object_name: ovarian cancer


subject: GTOPDB:7750

object_name: ovarian neoplasm


subject: GTOPDB:7750

object_name: ovarian carcinoma


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UNII:6HP0354G04


subject: UMLS:C2987611


subject: UMLS:C2987611


subject: UMLS:C2987611


subject: UMLS:C2987611


subject: UMLS:C2987611


subject: UMLS:C2987611


subject: UMLS:C2987611


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Clostridium difficile colitis


subject: PUBCHEM.COMPOUND:46783403

object_name: clostridium difficile infection


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: adult dermatomyositis


subject: UMLS:C0919144

object_name: dermatomyositis


subject: UMLS:C0919144

object_name: lung; disease, interstitial, with fibrosis


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Bone Mineral Density


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:O1GX33ON8R

subject_name: Alexomycin

object_name: COPD, severe early onset


subject: UNII:O1GX33ON8R

object_name: chronic obstructive pulmonary disease


subject: UNII:O1GX33ON8R

object_name: lung neoplasm


subject: UniProtKB:Q2YLX6

subject_name: RL25_BRUA2 Large ribosomal subunit protein bL25 (sprot)


subject: UniProtKB:Q2YLX6


subject: UniProtKB:Q2YLX6


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:52717

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:52717

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:52717

object_name: Adult Gliosarcoma


subject: CHEBI:52717

object_name: Adult Anaplastic Astrocytoma


subject: UNII:W248Y1AKOR

subject_name: Tovinontrine

object_name: diastolic heart failure


subject: CHEBI:7565

subject_name: Nifedipine

object_name: Pregnant


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Neck Carcinoma


subject: CHEBI:3215

object_name: head and neck neoplasm


subject: CHEBI:3215

object_name: head and neck cancer


subject: UMLS:C0146226

subject_name: Toradol

object_name: pain agnosia


subject: UMLS:C0146226

object_name: Pain insensitivity


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: UMLS:C0146226


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:6129


subject: UNII:Z0O4TJ588O

subject_name: Posiphen

object_name: Alzheimer disease


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]

object_name: Carcinoma breast stage IV


subject: CHEBI:90948

subject_name: osimertinib mesylate

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: Insulin resistance syndrome


subject: CHEBI:232469

object_name: adult lymphoma


subject: CHEBI:232469

object_name: lymphoma


subject: CHEBI:232469

object_name: pediatric lymphoma


subject: CHEBI:232469

object_name: Neoplasm Metastasis


subject: CHEBI:232469

object_name: neoplasm


subject: PUBCHEM.COMPOUND:154723996

subject_name: Heme arginate

object_name: atherosclerosis


subject: UNII:R1B526117P


subject: CHEBI:32682

subject_name: L-argininium


subject: CHEBI:29952

subject_name: L-arginine residue


subject: DRUGBANK:DB10559

subject_name: Pistachio

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB10559

object_name: cardiovascular disorder


subject: CHEBI:3219

subject_name: Bupropion

object_name: Restless legs


subject: CHEBI:124959

subject_name: Tilarginine

object_name: congestive heart failure


subject: UMLS:C0069477


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:68554

subject_name: Deferiprone

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:68554

object_name: amyotrophic lateral sclerosis


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: interstitial cystitis


subject: UMLS:C1446777

subject_name: Rabbit antigen

object_name: Crouzon syndrome-acanthosis nigricans syndrome


subject: UMLS:C2093603

subject_name: Rabbit


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Disorder related to bone marrow transplantation


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:Y0H7UPE4WJ


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: Community-Acquired Pneumonia


subject: GTOPDB:13334

subject_name: bezlotoxumab

object_name: Clostridioides difficile infection recurrence


subject: GTOPDB:13334

object_name: Organ dysfunction syndrome


subject: GTOPDB:13334

object_name: mortality


subject: UNII:4H5YMK1H2E

subject_name: Bezlotoxumab


subject: UNII:4H5YMK1H2E


subject: UNII:4H5YMK1H2E


subject: CHEMBL.COMPOUND:CHEMBL5095278

subject_name: LORIGERLIMAB

object_name: Prostatic Cancer, Castration-Resistant


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: nonpapillary renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: clear cell renal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: renal cell adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: adult hepatocellular carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: liver cancer


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: pediatric hepatocellular carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: malignant epithelial tumor of ovary


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UNII:2ZK3D69DQJ

subject_name: VOBRAMITAMAB DUOCARMAZINE


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UNII:2ZK3D69DQJ


subject: UMLS:C5204483

subject_name: Anti-B7H3 ADC


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: UMLS:C5204483


subject: CHEBI:31759

subject_name: Lafutidine

object_name: Heartburn


subject: CHEBI:33704

subject_name: Amino acid

object_name: Immune Tolerance


subject: CHEBI:33704

object_name: Drug Tolerance


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:15367

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:15367

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:15367

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:15367

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: coronary artery disorder


subject: CHEBI:46245

object_name: coronary atherosclerosis


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: pneumonitis


subject: UNII:M487QF2F4V

object_name: Pneumonitis, CTCAE


subject: UNII:M487QF2F4V

object_name: esophagitis


subject: UNII:M487QF2F4V

object_name: Esophagitis, CTCAE


subject: UNII:M487QF2F4V

object_name: non-small cell lung carcinoma


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: CHEBI:2636


subject: UMLS:C0082559

subject_name: Feiba

object_name: cardiovascular disorder


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: infertility


subject: UMLS:C5140568

subject_name: Thyrotropin Alfa for Injection

object_name: differentiated thyroid carcinoma


subject: CHEBI:125427

object_name: type 2 diabetes mellitus


subject: CHEBI:125427

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:125427

object_name: obesity


subject: CHEBI:125427

object_name: Obesity, CTCAE


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:31617

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:18216

object_name: nasopharyngeal carcinoma


subject: CHEBI:18216

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: PUBCHEM.COMPOUND:20057296

subject_name: Ganglioside GM1 (18:1/16:0)


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: CHEBI:177678

subject_name: Ganglioside GM1 (18:1/12:0)


subject: CHEBI:177678


subject: PUBCHEM.COMPOUND:20057297

subject_name: Sygen


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057299

subject_name: Ganglioside GM1 (18:1/22:0)


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: CHEBI:177701

subject_name: Ganglioside GM1 (18:1/9Z-18:1)


subject: CHEBI:177701


subject: PUBCHEM.COMPOUND:20057303

subject_name: Ganglioside GM1 (d18:1/24:0)


subject: PUBCHEM.COMPOUND:20057303


subject: CHEBI:73110

subject_name: ganglioside GM1(1-)


subject: CHEBI:73110


subject: CHEBI:61048

subject_name: Ganglioside GM1


subject: CHEBI:61048


subject: PUBCHEM.COMPOUND:20057298

subject_name: Ganglioside GM1 (18:1/20:0)


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:22833613

subject_name: Ganglioside GM1 (d18:1/25:0)


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:20057302

subject_name: Ganglioside GM1 (d18:1/26:0)


subject: PUBCHEM.COMPOUND:20057302


subject: UNII:QA3Y8EZG57

subject_name: Ivaltinostat

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:QA3Y8EZG57

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:QA3Y8EZG57

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:QA3Y8EZG57

object_name: Childhood Solid Neoplasm


subject: UNII:QA3Y8EZG57

object_name: Adult Solid Neoplasm


subject: UNII:QA3Y8EZG57

object_name: Solid Neoplasm


subject: UNII:QA3Y8EZG57

object_name: fibrosis


subject: UNII:4I8MLM7L2H


subject: UNII:4I8MLM7L2H


subject: UNII:4I8MLM7L2H


subject: UNII:4I8MLM7L2H


subject: UNII:4I8MLM7L2H


subject: UNII:4I8MLM7L2H


subject: UNII:4I8MLM7L2H


subject: CHEBI:59527

object_name: Impacted third molar tooth


subject: CHEBI:59527

object_name: Complication of other surgical procedures


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:50275


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UMLS:C4704928

subject_name: Antibody-Drug Conjugates

object_name: Childhood Breast Carcinoma


subject: UMLS:C4704928

object_name: breast carcinoma


subject: UMLS:C4704928

object_name: breast cancer


subject: UMLS:C4704928

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4704928

object_name: Embolism, Tumor


subject: UMLS:C4704928

object_name: Neoplasm Metastasis


subject: UMLS:C5418009

subject_name: BRAF Inhibitor BGB-3245

object_name: colorectal cancer


subject: UMLS:C5418009

object_name: colorectal carcinoma


subject: UMLS:C5418009

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:45783

subject_name: Imatinib

object_name: thyroid tumor


subject: CHEBI:45783

object_name: thyroid gland carcinoma


subject: CHEBI:45783

object_name: thyroid cancer


subject: CHEBI:42588

subject_name: Fenretinide

object_name: cervical cancer


subject: CHEBI:42588

object_name: cervical carcinoma


subject: CHEBI:42588

object_name: precancerous condition


subject: CHEBI:7789

subject_name: Orphenadrine

object_name: Cirrhosis


subject: CHEBI:7789

object_name: liver cirrhosis


subject: UNII:06IVK87M04

subject_name: Zelavespib

object_name: Carcinoma breast stage IV


subject: UMLS:C4310558


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Uses contraception (finding)


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:75551

object_name: non-small cell lung carcinoma


subject: CHEBI:231681

subject_name: olaratumab

object_name: glioblastoma


subject: CHEBI:231681

object_name: adult glioblastoma


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UNII:98B30EPP5S

object_name: neoplasm


subject: UNII:98B30EPP5S

object_name: Tumor Mass


subject: UNII:98B30EPP5S

object_name: Disseminated Malignant Neoplasm


subject: UNII:98B30EPP5S

object_name: Embolism, Tumor


subject: UNII:98B30EPP5S

object_name: Neoplasm Metastasis


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: brain disorder


subject: CHEBI:68841

object_name: spinal cord disorder


subject: UMLS:C3154257

subject_name: Gadavist


subject: UMLS:C3154257


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C0388020


subject: UMLS:C2713023


subject: UMLS:C2713023


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: chronic idiopathic urticaria


subject: UMLS:C2718754

subject_name: Ilaris


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: colorectal neoplasm


subject: UMLS:C2703138

subject_name: ficlatuzumab

object_name: lung cancer


subject: UMLS:C2703138

object_name: lung neoplasm


subject: UMLS:C2703138

object_name: lung carcinoma


subject: UMLS:C2703138

object_name: respiratory tract neoplasm


subject: CHEBI:49668

subject_name: Gefitinib


subject: UMLS:C0962969

subject_name: RAD 001

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:168429477

subject_name: Copper-64 labelled SAR-Bombesin

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:168429477

object_name: prostate cancer


subject: CHEBI:60775

subject_name: Verteporfin

object_name: Polypoidal choroidal vasculopathy


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban

object_name: Ischemic stroke


subject: CHEBI:3392

subject_name: Carbendazim

object_name: osteoarthritis, knee


subject: CHEBI:168480

subject_name: Desoxylimonin


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: esophageal cancer


subject: CHEBI:191174

object_name: Childhood Esophageal Carcinoma


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Stomach cancer


subject: UNII:15C2VL427D

object_name: gastric cancer


subject: UNII:15C2VL427D

object_name: carcinoma of esophagus


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D


subject: UNII:15C2VL427D

object_name: neoplasm of esophagus


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: Diabetic foot ulcer


subject: UMLS:C0279328

object_name: Amputated structure (morphologic abnormality)


subject: UMLS:C0279328

object_name: peripheral vascular disease


subject: CHEBI:193479

subject_name: N-Caffeoyltyramine

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:108018

subject_name: N-chlorotaurine


subject: CHEBI:73611

subject_name: Met-Gly

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:73611

object_name: acute myeloid leukemia


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Refractory Adult Acute Lymphoblastic Leukemia


subject: CHEBI:70839

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:70839

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:70839

object_name: Refractory Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5834084

object_name: coronary artery disorder


subject: UMLS:C5834084

object_name: coronary atherosclerosis


subject: CHEBI:57986

object_name: progressive keratoconus


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:66852

subject_name: lorcaserin hydrochloride hemihydrate

object_name: Overweight and obesity


subject: UMLS:C3485407

subject_name: Belviq


subject: PUBCHEM.COMPOUND:9891967

subject_name: Silodosin

object_name: nephrolithiasis, calcium oxalate


subject: PUBCHEM.COMPOUND:9891967

object_name: Ureteral Calculi


subject: PUBCHEM.COMPOUND:9891967

object_name: ureterolithiasis


subject: CHEBI:74926

subject_name: Patulin

object_name: Childhood Solid Neoplasm


subject: CHEBI:74926

object_name: Adult Solid Neoplasm


subject: CHEBI:74926

object_name: Solid Neoplasm


subject: CHEBI:74926

object_name: Embolism, Tumor


subject: CHEBI:74926

object_name: Neoplasm Metastasis


subject: CHEBI:74926

object_name: Metastasis


subject: CHEBI:74926

object_name: Metastatic Lesion


subject: UNII:K4H264PBQ7

subject_name: Fenamole


subject: UNII:K4H264PBQ7


subject: UNII:K4H264PBQ7


subject: UNII:K4H264PBQ7


subject: UNII:K4H264PBQ7


subject: UNII:K4H264PBQ7


subject: UNII:K4H264PBQ7


subject: PR:000023495

subject_name: putrescine aminotransferase


subject: PR:000023495


subject: PR:000023495


subject: PR:000023495


subject: PR:000023495


subject: PR:000023495


subject: PR:000023495


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: Albuminuria


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: CHEBI:75551


subject: UMLS:C3815568

object_name: kidney failure


subject: CHEBI:73726

subject_name: Cardarine

object_name: cardiovascular disorder


subject: CHEBI:73726

object_name: inherited lipid metabolism disorder


subject: CHEBI:73726

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:73726

object_name: obesity


subject: CHEBI:73726

object_name: Obesity, CTCAE


subject: CHEBI:30879

subject_name: alcohol

object_name: Drunk driving


subject: CHEBI:16236

subject_name: Ethanol


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: peripheral nervous system disorder


subject: UNII:4Z63YK6E0E

object_name: neuropathy


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602

object_name: monoclonal gammopathy of uncertain significance


subject: UMLS:C5383290

subject_name: hyaluronidase-fihj


subject: UMLS:C5383290


subject: UMLS:C5383290


subject: MESH:C492535

subject_name: RotaTeq

object_name: poliomyelitis


subject: PUBCHEM.COMPOUND:15251471

object_name: cannabis abuse


subject: CHEBI:44185

subject_name: Methotrexate

object_name: inflammatory bowel disease 1


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: UniProtKB:P47802

object_name: Crohn disease


subject: PR:000010755


subject: PR:000010755


subject: UMLS:C4722471

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C4722471

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:9449

subject_name: Terbutaline

object_name: status asthmaticus


subject: CHEBI:9449

object_name: Acute severe refractory exacerbation of asthma


subject: CHEBI:32696

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:32696

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: EXCESS LMW-DNA


subject: GTOPDB:13793

subject_name: tuvonralimab

object_name: biliary tract cancer


subject: GTOPDB:13793

object_name: liver carcinoma


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UNII:8XWO7LI4LO


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C5784793


subject: CHEBI:63630

subject_name: Tolcapone

object_name: schizophrenia


subject: UNII:0K5743G68X

subject_name: Lemborexant

object_name: Irregular sleep wake rhythm disorder


subject: CHEBI:15365

subject_name: Aspirin

object_name: Chronic kidney disease stage 5 on dialysis


subject: PUBCHEM.COMPOUND:57411069


subject: UNII:46P8AHZ243


subject: UNII:V0Q46LFE6F

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:V0Q46LFE6F

object_name: mantle cell lymphoma


subject: UNII:V0Q46LFE6F

object_name: marginal zone lymphoma


subject: UNII:V0Q46LFE6F

object_name: MALT lymphoma


subject: UNII:V0Q46LFE6F

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:9952054

subject_name: beta-CIT

object_name: Parkinson disease


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Hypercholesterolemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: diffuse large B-cell lymphoma germinal center B-cell type


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:73579

subject_name: Leu-Val

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:194537

subject_name: Livermorium


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: CHEBI:3757

subject_name: Clonidine

object_name: Surgical procedure finding


subject: UMLS:C5446553

subject_name: Boron-based Gel

object_name: radiodermatitis


subject: CHEBI:74061

subject_name: Ile-Arg

object_name: Restless legs


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: UMLS:C5203179

subject_name: Adalimumab Liquid Injection

object_name: frozen shoulder


subject: UMLS:C5203179

object_name: bursitis


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: UNII:FYS6T7F842


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Immunosuppression


subject: UNII:3A189DH42V

object_name: Decreased Immunologic Activity [PE]


subject: UNII:3A189DH42V

object_name: chronic kidney disease


subject: UNII:3A189DH42V

object_name: Chronic uremia


subject: UMLS:C0302908

subject_name: Liquid substance

object_name: Overweight


subject: CHEBI:230791

subject_name: tributyrylglycerol

object_name: Alzheimer disease


subject: CHEBI:35020

subject_name: Tributyrin


subject: UMLS:C0031237

subject_name: pertussis vaccine

object_name: relapsing-remitting multiple sclerosis


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: DRUGBANK:DB10989

subject_name: Hepatitis A Vaccine


subject: UMLS:C0062527

subject_name: Engerix-B


subject: UMLS:C0593408

subject_name: Tick-borne encephalitis vaccine


subject: UMLS:C3272840

subject_name: meningococcal polysaccharide vaccine (MPSV4)


subject: UMLS:C2960908

subject_name: Meningococcal vaccine component


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: neoplasm


subject: UMLS:C0282090

subject_name: Laxatives

object_name: metabolic disease


subject: UMLS:C0282090

object_name: Diet, Healthy


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: Constipation


subject: CHEBI:8665

object_name: Constipation, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4650287

object_name: neurodegenerative disease


subject: UNII:SE2KH7T06F

object_name: urothelial carcinoma


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: transitional cell carcinoma


subject: CHEBI:2704

subject_name: Anastrozole

object_name: non-small cell lung carcinoma


subject: UMLS:C0013230

subject_name: Investigational New Drugs

object_name: Burn injury


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Thyroid cancer metastatic


subject: PR:000001379


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Spastic foot


subject: CHEBI:31539

subject_name: Epalrestat

object_name: Charcot-Marie-Tooth disease


subject: CHEBI:31539

object_name: hereditary motor and sensory neuropathy


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:135207

subject_name: Clofedanol

object_name: bipolar disorder


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: Childhood Breast Carcinoma


subject: CHEBI:50223

object_name: breast carcinoma


subject: CHEBI:50223

object_name: breast cancer


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Drug toxicity


subject: CHEBI:18145

subject_name: Vitamin E

object_name: lung cancer


subject: CHEBI:18145

object_name: lung neoplasm


subject: CHEBI:18145

object_name: lung carcinoma


subject: CHEBI:18145


subject: CHEBI:27013

subject_name: Tocopherol


subject: CHEBI:27013


subject: CHEBI:27013


subject: CHEBI:27013


subject: UMLS:C1709400

object_name: head and neck neoplasm


subject: CHEBI:132268

subject_name: Dacomitinib


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Skin Pain


subject: CHEBI:28918

object_name: Musculoskeletal Pain


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: chorioamnionitis


subject: CHEBI:46195

object_name: Intrapartum fever


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:62088

subject_name: Metamizole


subject: CHEBI:62088


subject: CHEBI:27470

subject_name: Folic acid

object_name: coronary atherosclerosis


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Secondary malignant neoplasm of lung


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: Wilson disease


subject: CHEBI:64019

subject_name: Nebivolol

object_name: Duchenne muscular dystrophy


subject: CHEBI:64019

object_name: heart failure


subject: CHEBI:64019

object_name: Heart Failure, CTCAE


subject: CHEBI:64019

object_name: cardiomyopathy


subject: CHEBI:49960

subject_name: Vandetanib

object_name: carcinoma of esophagus


subject: CHEBI:49960

object_name: esophageal cancer


subject: CHEBI:49960


subject: UMLS:C4078046

object_name: staphylococcus aureus pneumonia


subject: CHEBI:17026

subject_name: Progesterone

object_name: Secondary amenorrhea


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: PUBCHEM.COMPOUND:20802597

subject_name: Sapacitabine

object_name: primary cutaneous T-cell lymphoma


subject: UNII:LMQ24G57E9

subject_name: Daridorexant

object_name: Insomnia, CTCAE 3.0


subject: UNII:LMQ24G57E9

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:44915

subject_name: Propofol

object_name: Mental deterioration


subject: CHEBI:62097

object_name: gastric adenocarcinoma


subject: CHEBI:33367

subject_name: darmstadtium


subject: CHEBI:34699

subject_name: diethyl sulfate


subject: CHEBI:73454

subject_name: Asp-Ser


subject: CHEBI:4659

subject_name: Disulfiram


subject: UNII:07JNL92FG4

object_name: coronary artery disorder


subject: CHEBI:41423

subject_name: Celecoxib

object_name: anterior uveitis


subject: CHEBI:41423

object_name: ulcerative colitis


subject: CHEBI:59905

object_name: Postoperative cognitive dysfunction


subject: CHEBI:18243

subject_name: Dopamine


subject: CHEBI:15407

subject_name: Ephedrine


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:8093

subject_name: Phenylephrine


subject: UMLS:C5417797

subject_name: PPAR Alpha Antagonist TPST-1120

object_name: liver carcinoma


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Acute chest pain


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Urinary Urgency


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Disorder of vitamin C


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Menopause present (finding)


subject: CHEBI:76016

object_name: Menopause


subject: CHEBI:76016

object_name: Vasomotor disturbance


subject: CHEBI:76016

object_name: Hot Flashes, CTCAE


subject: CHEBI:76016

object_name: Hot flashes


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: colorectal neoplasm


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Recurrence


subject: UNII:L500PR95QA

object_name: Recurrent Malignant Neoplasm


subject: UNII:L500PR95QA

object_name: Recurrent disease


subject: UNII:L500PR95QA

object_name: Recurrent tumor


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: renal carcinoma


subject: UNII:PVI5M0M1GW

object_name: kidney neoplasm


subject: UNII:PVI5M0M1GW

object_name: kidney cancer


subject: UNII:PVI5M0M1GW

object_name: skin melanoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes


subject: CHEBI:92511

subject_name: Ketotifen

object_name: neuropathy


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: malnutrition


subject: UNII:L500PR95QA


subject: CHEBI:6909


subject: UMLS:C5556548

subject_name: CD122-selective IL-2/Anti-CD25 Antibody-like Fusion Protein ANV419

object_name: Plasma cell myeloma refractory


subject: UMLS:C5556548

object_name: plasma cell myeloma


subject: UMLS:C5556548

object_name: Recurrent Carcinoma


subject: UMLS:C5556548

object_name: hematologic disorder


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E


subject: UNII:4Z63YK6E0E

object_name: adult disease


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: UMLS:C5706445

subject_name: RAS Inhibitor RMC-6236

object_name: pancreatic ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:168201327


subject: UMLS:C5907933

subject_name: KRAS G12D Inhibitor RMC-9805


subject: UMLS:C4086733

subject_name: EPO 018B

object_name: Myelodysplasia


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Itchiness


subject: PUBCHEM.COMPOUND:50913622

subject_name: Delgocitinib


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: glioma


subject: UNII:G8RGG88B68

object_name: malignant glioma


subject: GTOPDB:4985

object_name: liver disorder


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Thrombus of cardiac chamber


subject: CHEBI:68579

object_name: Intracardiac Thrombus Related to COVID-19


subject: UMLS:C5238987

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5238987

object_name: clear cell renal carcinoma


subject: CHEBI:81569

subject_name: Follitropin

object_name: Follicle stimulating hormone deficiency


subject: UMLS:C0309130

subject_name: Follutein


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: Invasive fungal infection


subject: CHEBI:31215

subject_name: anecortave

object_name: glycogen storage disease II


subject: CHEBI:47499

subject_name: Imipramine

object_name: glioblastoma


subject: CHEBI:47499

object_name: Childhood Glioblastoma


subject: CHEBI:47499

object_name: adult glioblastoma


subject: UMLS:C2003425

object_name: schizophrenia


subject: MESH:C000632565

subject_name: symtuza

object_name: HIV infection


subject: UMLS:C0879272

object_name: Childhood Breast Carcinoma


subject: UMLS:C0879272

object_name: breast carcinoma


subject: UMLS:C0879272

object_name: breast cancer


subject: UMLS:C0879272

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0879272

object_name: leukemia


subject: UMLS:C0879272

object_name: childhood leukemia


subject: UMLS:C0879272

object_name: adult lymphoma


subject: UMLS:C0879272

object_name: lymphoma


subject: UMLS:C0879272

object_name: pediatric lymphoma


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEMBL.COMPOUND:CHEMBL4650376

subject_name: AUTOGENE CEVUMERAN

object_name: Muscle invasive urothelial carcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: bariatric surgery candidate


subject: CHEBI:4466

object_name: morbid obesity


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:6121

subject_name: Ketamine


subject: UMLS:C5238987

object_name: Small cell lung cancer recurrent


subject: UMLS:C5238987

object_name: Small cell lung cancer extensive stage


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Bladder cancer recurrent


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: bipolar depression


subject: UMLS:C1721343

subject_name: dorzolamide / timolol

object_name: ocular hypertension


subject: UMLS:C1721343

object_name: Ocular hypertension


subject: UMLS:C1721343

object_name: open-angle glaucoma


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Gender Dysphoria


subject: CHEBI:28787

object_name: gender incongruence


subject: PUBCHEM.COMPOUND:58265877

object_name: type 2 diabetes mellitus


subject: CHEBI:5558

subject_name: Guanfacine

object_name: Adult attention deficit hyperactivity disorder


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: prolymphocytic leukemia


subject: CHEBI:93755


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: diabetic kidney disease


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Pregnant


subject: CHEBI:50172

subject_name: acitretin

object_name: exanthem


subject: CHEBI:50174


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: atrial flutter


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Atrial Flutter by ECG Finding


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Atrial Flutter, CTCAE


subject: CHEBI:84040

object_name: glycogen storage disease II


subject: CHEBI:84040

object_name: choroidal neovascularization


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: UMLS:C1101322

subject_name: trans-Resveratrol

object_name: age-related macular degeneration


subject: UMLS:C1101322


subject: UMLS:C1101322


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:10127

subject_name: Zonisamide

object_name: fibromyalgia


subject: CHEBI:47554

subject_name: Ethyl chloride

object_name: Shoulder pain


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: exocrine pancreatic carcinoma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:114785

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:114785

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:114785

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:114785

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:114785

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:31824

subject_name: Mesna

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:31824

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:31824

object_name: childhood myelodysplastic syndrome


subject: CHEBI:31824

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:6121

subject_name: Ketamine

object_name: Rett syndrome


subject: CHEBI:94534

subject_name: olanzapine

object_name: Gambling


subject: UMLS:C0093142

object_name: hypercholesterolemia, familial, 1


subject: UMLS:C0093142

object_name: familial hypercholesterolemia


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: cryptosporidiosis


subject: CHEMBL.COMPOUND:CHEMBL1201660

subject_name: SAFFLOWER OIL

object_name: pervasive developmental disorder


subject: CHEMBL.COMPOUND:CHEMBL1201660

object_name: autism


subject: CHEMBL.COMPOUND:CHEMBL1201660

object_name: autism spectrum disorder


subject: CHEMBL.COMPOUND:CHEMBL1201660

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEMBL.COMPOUND:CHEMBL1201660


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: HIV infection


subject: CHEBI:15966

subject_name: D-Glutamic Acid

object_name: multiple sclerosis


subject: CHEBI:14321


subject: CHEBI:29987


subject: CHEBI:16015

subject_name: Glutamic acid


subject: UMLS:C0017789

subject_name: Glutamates


subject: CHEBI:29995


subject: CHEBI:29991


subject: CHEBI:72314

subject_name: aspartate salt


subject: CHEBI:132943

subject_name: aspartate


subject: UMLS:C0085845


subject: CHEBI:22660

subject_name: aspartic acid


subject: UMLS:C1165603

subject_name: Dextrose solution

object_name: Myofascial pain syndrome of neck


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:3219

subject_name: Bupropion

object_name: binge eating


subject: PR:000004614

subject_name: bile acid-CoA:amino acid N-acyltransferase


subject: PR:000004614

object_name: severe acute respiratory syndrome


subject: PR:000004614

object_name: cytokine release syndrome


subject: PR:000004614

object_name: Cytokine Release Syndrome, CTCAE


subject: PR:000004614

object_name: Cytokine storm


subject: CHEBI:181423

subject_name: CALCIFEDIOL


subject: CHEBI:181423


subject: CHEBI:181423


subject: CHEBI:181423


subject: CHEBI:181423


subject: UMLS:C3714609

subject_name: Calcifediol Drug Class


subject: UMLS:C3714609


subject: UMLS:C3714609


subject: UMLS:C3714609


subject: UMLS:C3714609


subject: CHEBI:17933

subject_name: Calcifediol


subject: CHEBI:17933


subject: CHEBI:17933


subject: CHEBI:17933


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Adverse effects in the therapeutic use of immunosuppressive agents


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227

object_name: Chronic uremia


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Stomach cancer


subject: UNII:CJN36EQM0H

object_name: gastric cancer


subject: UMLS:C4045716

object_name: Olmsted syndrome


subject: UMLS:C4045716

object_name: Olmsted syndrome 1


subject: CHEBI:92511

subject_name: Ketotifen

object_name: Pleural effusion


subject: CHEBI:92511

object_name: Pleural Effusion, CTCAE


subject: CHEBI:92511

object_name: x-ray of chest: pleural effusion


subject: CHEBI:92511

object_name: dengue disease


subject: UMLS:C0085155

subject_name: Generic Drugs

object_name: Skin Manifestations


subject: UMLS:C0021745

subject_name: interferon type II

object_name: chronic prostatitis


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: CHEBI:187893

subject_name: Baclofen

object_name: bulimia nervosa


subject: CHEBI:187893

object_name: eating disorder


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: cleft palate


subject: CHEBI:60789

object_name: isolated cleft palate


subject: CHEBI:60789

object_name: cleft palate on exam


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:52763

object_name: rheumatoid arthritis


subject: UMLS:C0017132

subject_name: Gastric Inhibitory Polypeptide

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:44216444

subject_name: xenin


subject: UMLS:C0527368

subject_name: xenin 25


subject: UNII:6A1X56B95E

subject_name: Rapastinel

object_name: endogenous depression


subject: UMLS:C1666271

subject_name: GLYX-13 peptide


subject: CHEBI:145304

subject_name: monoacylglycerol 22:5


subject: CHEBI:145304

object_name: major depressive disorder


subject: CHEBI:125628

subject_name: Alisertib

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:125628

object_name: stage IV pancreatic cancer


subject: CHEBI:125628

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:125628

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:125628

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:125628

object_name: Pancreatic carcinoma stage III


subject: CHEBI:125628

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:125628

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:125628

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:48775

object_name: Parkinson disease


subject: CHEBI:8673

subject_name: Pyrimethamine


subject: CHEBI:22977

subject_name: Cadmium


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:81686

subject_name: Magnesium L-ascorbic acid-2-phosphate


subject: CHEBI:28055

subject_name: aminoparathion


subject: CHEBI:155848

subject_name: Ala-Pro


subject: CHEBI:28971

subject_name: Ampicillin


subject: UMLS:C0002059

subject_name: Alkaline Phosphatase


subject: CHEBI:49183


subject: CHEBI:55395

subject_name: phosphocholine group


subject: CHEBI:17361

subject_name: CMP


subject: CHEBI:57643


subject: CHEBI:76073


subject: CHEBI:16110


subject: CHEBI:53201

subject_name: Polycarbonates


subject: CHEBI:61433

subject_name: polycarbonate polymer


subject: UMLS:C1831890

object_name: metastatic colorectal cancer


subject: UNII:681K1JDI8M

subject_name: Valoctocogene roxaparvovec

object_name: blood coagulation disease


subject: UNII:681K1JDI8M

object_name: hematologic disorder


subject: CHEBI:132975

subject_name: Grazoprevir

object_name: HIV infection


subject: CHEBI:60802

subject_name: ropivacaine

object_name: abdominal aortic aneurysm


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: head and neck squamous cell carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UMLS:C0751598

subject_name: Alferon

object_name: DS Stage I Plasma Cell Myeloma


subject: UMLS:C0751598

object_name: ISS Stage I Plasma Cell Myeloma


subject: UMLS:C0751598

object_name: DS Stage II Plasma Cell Myeloma


subject: UMLS:C0751598

object_name: ISS Stage II Plasma Cell Myeloma


subject: UMLS:C0751598

object_name: ISS Stage III Plasma Cell Myeloma


subject: UMLS:C0751598

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C0751598

object_name: Plasma cell myeloma refractory


subject: CHEBI:25805

subject_name: oxygen atom

object_name: anxiety


subject: CHEBI:25805

object_name: anxiety disorder


subject: CHEBI:25805

object_name: Anxiety symptoms


subject: CHEBI:25805

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:25805

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Peripheral neuropathic pain


subject: CHEBI:3215

object_name: neuralgia


subject: CHEBI:3215

object_name: Neuralgia, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6801

subject_name: Metformin

object_name: leprosy


subject: CHEBI:6801

object_name: multibacillary leprosy


subject: CHEBI:6801

object_name: Neglected Tropical Diseases


subject: CHEBI:231683

subject_name: Anakinra

object_name: metastatic colorectal cancer


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: female infertility


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359

object_name: Androgen excess


subject: CHEBI:59213

subject_name: Cefpiramide

object_name: Atopic rhinitis


subject: CHEBI:59213

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:59213

object_name: Nasal Congestion, CTCAE


subject: CHEBI:59213

object_name: Nasal congestion


subject: CHEBI:195334


subject: CHEBI:195334


subject: CHEBI:195334


subject: CHEBI:195334


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:6801

object_name: Mountain Sickness


subject: CHEBI:6801

object_name: acute mountain sickness


subject: CHEBI:6801

object_name: altitude sickness


subject: CHEBI:25567

subject_name: Nitrous acid


subject: CHEBI:25567


subject: CHEBI:25567


subject: CHEBI:16301

subject_name: Nitrite


subject: CHEBI:16301


subject: CHEBI:16301


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:16243


subject: UMLS:C4725693

subject_name: FGFR1/2/3 Inhibitor HMPL-453


subject: CHEMBL.COMPOUND:CHEMBL4650297


subject: CHEBI:67194

subject_name: Nabiximols

object_name: Advanced cancer


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: endometrial cancer


subject: GTOPDB:13791

object_name: uterine corpus cancer


subject: GTOPDB:13791

object_name: endometrial carcinoma


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Helicobacter pylori infection


subject: CHEBI:49086


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:233197

subject_name: devimistat

object_name: Progressive cGVHD


subject: CHEBI:233197

object_name: Progressive Disease


subject: CHEBI:233197

object_name: Progressive Neoplastic Disease


subject: CHEBI:233197

object_name: IMWG Progressive Disease


subject: CHEBI:233197

object_name: irPD (Immune-Related Response Criteria)


subject: CHEBI:233197

object_name: Global Progressive Disease in Viscera


subject: CHEBI:233197

object_name: RECIL PD


subject: CHEBI:233197

object_name: Global Progressive Disease in Skin


subject: CHEBI:233197

object_name: Global Progressive Disease


subject: CHEBI:233197

object_name: Global Progressive Disease in Lymph Nodes


subject: CHEBI:233197

object_name: Global Progressive Disease in Blood


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: UMLS:C2703200


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Myelodysplasia


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: esophageal squamous cell carcinoma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:37956

subject_name: histamine antagonist


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C0019593

subject_name: Histamine H2 Antagonists


subject: UMLS:C3536872

subject_name: Histamine-2 Receptor Antagonist [EPC]


subject: UMLS:C5205034


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: CHEBI:84500

subject_name: varenicline

object_name: Alzheimer disease


subject: MESH:C526287

object_name: Blood Clot


subject: MESH:C526287

object_name: thrombosis


subject: MESH:C526287

object_name: Thrombosis of blood vessel


subject: CHEBI:15365

subject_name: Aspirin

object_name: thrombocytopenia


subject: UMLS:C5782776

subject_name: BUPivacaine 0.5% preservative-free injectable solution

object_name: Emergence Delirium


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: Displacement of cervical intervertebral disc


subject: UMLS:C2240391

object_name: Displacement of lumbar intervertebral disc


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:63791

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:63791


subject: CHEBI:63791

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:63791

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:63791

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:63791

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:63791

object_name: Acute myeloid leukemia in remission


subject: CHEBI:63791

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:63791

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:63791

object_name: acute biphenotypic leukemia


subject: CHEBI:63791

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:63791

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: ISS Stage III Plasma Cell Myeloma


subject: UNII:4F4X42SYQ6

object_name: DS Stage III Plasma Cell Myeloma


subject: UNII:4F4X42SYQ6

object_name: ISS Stage II Plasma Cell Myeloma


subject: UNII:4F4X42SYQ6

object_name: DS Stage II Plasma Cell Myeloma


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C0295415

object_name: Treatment related acute myeloid leukaemia


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage II Bladder Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Bladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Bladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: urethral carcinoma associated with invasive bladder cancer


subject: PUBCHEM.COMPOUND:2767

object_name: bladder squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Distal Urethral Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: posterior urethra cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Proximal Urethral Carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: UMLS:C1541478

subject_name: Astuprotimut-R

object_name: Childhood Neuroblastoma


subject: UMLS:C1541478

object_name: neuroblastoma


subject: UMLS:C1541478

object_name: Osteosarcoma


subject: UMLS:C1541478

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C1541478

object_name: rhabdomyosarcoma


subject: UMLS:C1541478

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C1541478

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C0459796

subject_name: Insect Venoms

object_name: Allergy to bee venom


subject: UMLS:C4724850

subject_name: Lactobacillus reuteri Probiotic Tablet

object_name: Functional constipation


subject: UMLS:C4727161

subject_name: Glucocorticoid Receptor Antagonist CORT125281

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: metastatic melanoma


subject: CHEBI:93786


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Unresectable Breast Carcinoma


subject: CHEBI:233362

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:233362

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694


subject: UMLS:C4287690

object_name: Metastatic Breast Carcinoma


subject: UMLS:C4287690

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4287690

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:49603

subject_name: Lapatinib

object_name: glioma


subject: CHEBI:49603

object_name: malignant glioma


subject: CHEBI:49603

object_name: glioblastoma


subject: CHEBI:49603

object_name: Brain Stem Glioblastoma


subject: CHEBI:49603

object_name: glioma susceptibility 1


subject: CHEBI:49603

object_name: Gerstmann syndrome


subject: CHEBI:49603

object_name: Adenomatous colonic polyposis


subject: CHEBI:49603

object_name: Adult Gliosarcoma


subject: CHEBI:49603

object_name: gliosarcoma


subject: CHEBI:49603

object_name: Childhood Gliosarcoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: kidney disorder


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Malignant Bowel Obstruction


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:7726

subject_name: octreotide


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: castration-resistant prostate carcinoma


subject: UNII:MRL3739G66

object_name: metastatic prostate carcinoma


subject: UNII:MRL3739G66

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:2Z03364G96

subject_name: Dapansutrile

object_name: Parkinson disease


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Compulsion


subject: UNII:CVX52RV2DC

subject_name: TELISOTUZUMAB ADIZUTECAN

object_name: metastatic colorectal cancer


subject: CHEBI:90942

subject_name: Ixazomib

object_name: POEMS syndrome


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: nephritis


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:83G67E21XI

subject_name: Urokinase

object_name: pleural empyema


subject: UNII:83G67E21XI

object_name: empyema


subject: UNII:83G67E21XI

object_name: pneumonia


subject: UNII:83G67E21XI

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0701941

subject_name: Abbokinase


subject: UMLS:C0701941


subject: UMLS:C0701941


subject: UMLS:C0701941


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Advanced Lung Non-Small Cell Squamous Carcinoma


subject: CHEBI:231614

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:231614

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: CHEBI:231614

object_name: PD-L1 Overexpression


subject: CHEBI:231614

object_name: PD-L1 Positive


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C1452745

object_name: acute liver failure


subject: UMLS:C1452745

object_name: Acute on chronic hepatic failure


subject: UMLS:C1452745

object_name: alcoholic hepatitis


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:6367

object_name: obesity


subject: CHEBI:6367

object_name: Obesity, CTCAE


subject: CHEBI:6367

object_name: binge eating


subject: CHEBI:3892

subject_name: Corticotropin

object_name: glomerulonephritis


subject: CHEBI:41264

subject_name: butyl group

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:41264

object_name: childhood myelodysplastic syndrome


subject: CHEBI:41264

object_name: Myelodysplastic Syndrome, CTCAE


subject: PR:000022673

subject_name: antigen 43


subject: PR:000022673


subject: PR:000022673


subject: UMLS:C4724855

subject_name: BCD 100

object_name: cervical cancer


subject: UMLS:C4724855

object_name: cervical carcinoma


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: Choroidal retinal neovascularization


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: CHEBI:63607

subject_name: Linezolid

object_name: Thrombocytopenia caused by drugs


subject: CHEBI:132922

object_name: mental disorder


subject: CHEBI:132922

object_name: psychiatric disorder


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: major depressive disorder


subject: CHEBI:58097

object_name: colorectal cancer


subject: CHEBI:58097

object_name: colorectal carcinoma


subject: CHEBI:58097

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:135699

subject_name: Piritramide


subject: CHEBI:135699


subject: CHEBI:135699


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C3827082


subject: CHEMBL.COMPOUND:CHEMBL4650376

subject_name: AUTOGENE CEVUMERAN


subject: UMLS:C1446647

subject_name: Milk antigen

object_name: Upper Respiratory Infections


subject: UMLS:C1446647

object_name: respiratory tract infectious disorder


subject: UMLS:C1446647

object_name: diarrhea


subject: UMLS:C1446647

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C1446647

object_name: Diarrhea, CTCAE


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: GTOPDB:9098

subject_name: carotuximab

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109321

subject_name: CAROTUXIMAB


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: complications of organ transplant stem cells


subject: CHEBI:73604

object_name: Hodgkin Disease


subject: UMLS:C2744846

subject_name: CYT 387


subject: UMLS:C2744846

object_name: Post-polycythemia vera myelofibrosis


subject: UMLS:C2744846

object_name: myelofibrosis


subject: UMLS:C4087001

object_name: rosacea


subject: UNII:618SLL9VBS

subject_name: Omiganan


subject: UMLS:C4550028


subject: GTOPDB:10659

subject_name: bempegaldesleukin

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: GTOPDB:10659

object_name: Head and neck cancer metastatic


subject: CHEMBL.COMPOUND:CHEMBL4298058

subject_name: BEMPEGALDESLEUKIN


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Myalgia, CTCAE


subject: CHEBI:3160

object_name: Myalgia


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: metastatic melanoma


subject: UMLS:C4721782

object_name: skin neoplasm


subject: UMLS:C4721782

object_name: skin cancer


subject: UMLS:C4721782

object_name: childhood neoplasm


subject: UMLS:C4721782

object_name: neoplastic syndrome


subject: UMLS:C4721782

object_name: cancer or benign tumor


subject: UMLS:C4721782

object_name: neoplasm


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: Compensated cirrhosis


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: UMLS:C3640822

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3640822

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C3640822

object_name: Adenocarcinoma of the prostate metastatic


subject: UMLS:C3640822

object_name: Prostate Carcinoma Metastatic in the Bone


subject: UMLS:C3640822

object_name: Prostate Carcinoma Metastatic in the Soft Tissue


subject: UMLS:C3640822

object_name: Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents


subject: UMLS:C3640822

object_name: Castration Levels of Testosterone


subject: UMLS:C3640822

object_name: Testosterone Less than 50 ng/dL


subject: UMLS:C3640822

object_name: Progressive cGVHD


subject: UMLS:C3640822

object_name: Progressive Disease


subject: UMLS:C3640822

object_name: Progressive Neoplastic Disease


subject: UMLS:C3640822

object_name: IMWG Progressive Disease


subject: UMLS:C3640822

object_name: irPD (Immune-Related Response Criteria)


subject: UMLS:C3640822

object_name: Global Progressive Disease in Viscera


subject: UMLS:C3640822

object_name: RECIL PD


subject: UMLS:C3640822

object_name: Global Progressive Disease in Skin


subject: UMLS:C3640822

object_name: Global Progressive Disease


subject: UMLS:C3640822

object_name: Global Progressive Disease in Lymph Nodes


subject: UMLS:C3640822

object_name: Global Progressive Disease in Blood


subject: UMLS:C3640822

object_name: PSA Progression


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: metastatic colorectal cancer


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:29108

subject_name: Calcium cation

object_name: esophageal cancer


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: infertility


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:2704

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:2704

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:2704

object_name: invasive ductal breast carcinoma


subject: CHEBI:2704

object_name: invasive lobular breast carcinoma


subject: CHEBI:91951

object_name: Breast cancer stage II


subject: CHEBI:91951

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:91951

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:233197

subject_name: devimistat

object_name: biliary tract cancer


subject: CHEBI:233197

object_name: liver carcinoma


subject: UNII:E76113IR49

subject_name: Devimistat


subject: UNII:E76113IR49


subject: UMLS:C2703200

subject_name: CPI 613


subject: UMLS:C2703200


subject: UMLS:C5206920

object_name: Systolic Hypertension


subject: PUBCHEM.COMPOUND:71300864


subject: UMLS:C2933615

subject_name: LCZ 696


subject: CHEBI:9927

subject_name: Valsartan


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: Primary malignant neoplasm


subject: UNII:DWN2WN457X

object_name: cancer


subject: UNII:DWN2WN457X

object_name: childhood malignant neoplasm


subject: UNII:DWN2WN457X

object_name: Malignant obstetric neoplasm


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:50885


subject: CHEBI:50885


subject: CHEBI:50885


subject: PUBCHEM.COMPOUND:3370

subject_name: Fludrocortisone acetate


subject: PUBCHEM.COMPOUND:3370


subject: PUBCHEM.COMPOUND:3370


subject: PUBCHEM.COMPOUND:3370


subject: CHEBI:16962

subject_name: Cortisone


subject: CHEBI:16962


subject: CHEBI:16962


subject: CHEBI:16962


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: UMLS:C5907894


subject: UMLS:C5907894


subject: UMLS:C5907894


subject: UMLS:C5907894


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: UMLS:C5237476

subject_name: Rescue Medications


subject: UMLS:C5237476


subject: UMLS:C5237476


subject: UMLS:C5237476


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: UNII:BNL5ERR07R

object_name: Immune Tolerance


subject: UNII:BNL5ERR07R

object_name: Drug Tolerance


subject: UNII:BNL5ERR07R

object_name: Safety Issues


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Hodgkin Disease


subject: CHEBI:231679

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:681569

subject_name: Clofarabine

object_name: acute myeloid leukemia with minimal differentiation


subject: UMLS:C5392516

object_name: ventilator-associated pneumonia


subject: UMLS:C5392516

object_name: staphylococcal pneumonia


subject: UMLS:C1328240

subject_name: XYOTAX

object_name: prostate cancer


subject: UMLS:C1328240

object_name: prostate neoplasm


subject: UNII:KXF3755R6D

subject_name: Lysergic Acid Diethylamide Tartrate

object_name: Encounter due to palliative care


subject: UNII:KXF3755R6D

object_name: outcomes general quality of life


subject: UNII:KXF3755R6D

object_name: Perceived quality of life


subject: UNII:KXF3755R6D

object_name: Good quality of life


subject: UNII:KXF3755R6D

object_name: anxiety


subject: UNII:KXF3755R6D

object_name: anxiety disorder


subject: UNII:KXF3755R6D

object_name: Anxiety symptoms


subject: UNII:KXF3755R6D

object_name: Anxiety, CTCAE 3.0


subject: UNII:KXF3755R6D

object_name: Anxiety, CTCAE 5.0


subject: UNII:KXF3755R6D

object_name: Depressed mood


subject: UNII:KXF3755R6D

object_name: Cancer patients and suicide and depression


subject: UNII:KXF3755R6D

object_name: Depressed - symptom


subject: UNII:KXF3755R6D

object_name: Depression, CTCAE


subject: UNII:KXF3755R6D

object_name: Fear of death


subject: UNII:KXF3755R6D

object_name: Necrophobia


subject: UNII:KXF3755R6D

object_name: Psychological Distress


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C0024335


subject: UMLS:C3274627

subject_name: Synbiotic Supplement

object_name: schizophrenia


subject: UMLS:C3274627

object_name: schizoaffective disorder


subject: UMLS:C3274627

object_name: schizophrenia 18


subject: MESH:C000602558

object_name: refractory malignant neoplasm


subject: UNII:VV3HN9ZPB5

subject_name: FOLLITROPIN ALFA

object_name: Ovarian failure


subject: CHEBI:81569

subject_name: Follitropin


subject: UMLS:C4759807

subject_name: TSH, alpha Subunit


subject: UMLS:C1268876

subject_name: follitropin alfa


subject: UNII:2M2GGL7HUP

subject_name: FOLLITROPIN DELTA


subject: UMLS:C4301617

subject_name: follitropin delta


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C0025326

subject_name: Menotropins


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: morbid obesity


subject: UNII:LIA7Z4002P

object_name: bypass complications


subject: MESH:C000605452

subject_name: guizhi-shaoyao-zhimu decoction

object_name: Arthralgia


subject: MESH:C000605452

object_name: Arthralgia, CTCAE


subject: CHEBI:91402

subject_name: linsitinib

object_name: Refractory Ewing Sarcoma


subject: UNII:15A52GPT8T

subject_name: Linsitinib


subject: CHEBI:9356

subject_name: Sultopride

object_name: Addiction


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:7465

subject_name: Naltrexone


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: plasma cell myeloma


subject: UMLS:C3696061

subject_name: saffron extract

object_name: mood disorder


subject: UMLS:C3696061

object_name: Computer vision syndrome


subject: UMLS:C3696061

object_name: sleep disorder


subject: UMLS:C1446433

subject_name: Crocus sativus antigen


subject: UMLS:C1446433


subject: UMLS:C1446433


subject: PUBCHEM.COMPOUND:9995208

subject_name: Estetrol

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:9995208

object_name: Menopause


subject: UMLS:C0357949

subject_name: topical antihistamine

object_name: Inflammation


subject: UMLS:C0357949

object_name: pterygium


subject: UMLS:C0357949

object_name: conjunctival pterygium


subject: UMLS:C0042397

subject_name: Vasoconstrictor Agents


subject: UMLS:C0042397


subject: UMLS:C0042397


subject: UMLS:C4255305

subject_name: Vasoconstrictor [EPC]


subject: UMLS:C4255305


subject: UMLS:C4255305


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: HIV infection


subject: CHEBI:32020

subject_name: Pitavastatin


subject: MESH:D013662

subject_name: Tea

object_name: stomatitis


subject: CHEBI:28621

subject_name: Trolamine


subject: CHEBI:35026

subject_name: triethylamine


subject: PR:000015198

subject_name: cationic amino acid transporter 2


subject: CHEBI:49086

object_name: glaucoma


subject: CHEBI:49086

object_name: Glaucoma, CTCAE


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:5378597

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:5378597

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:68352

subject_name: Isoquercetin


subject: CHEBI:68352


subject: CHEBI:95021

subject_name: pemetrexed

object_name: cervical intraepithelial neoplasia


subject: CHEBI:95021

object_name: dysplasia of cervix


subject: CHEBI:63724


subject: CHEBI:63724


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: HER2/Neu Negative


subject: GTOPDB:13792

object_name: HER2 negative


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: GTOPDB:13793


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UNII:8XWO7LI4LO


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C5784793


subject: UMLS:C5206815


subject: UMLS:C5206815


subject: CHEBI:167638

subject_name: Labetalol

object_name: hypertensive urgency


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: type 2 diabetes mellitus


subject: UMLS:C1313807


subject: CHEBI:6456

subject_name: Lidocaine

object_name: stroke disorder


subject: CHEBI:6456

object_name: cerebrovascular disorder


subject: CHEBI:6456

object_name: Stroke (heart beat)


subject: CHEBI:6456

object_name: Stroke, CTCAE


subject: CHEBI:45652

subject_name: Succinylcholine


subject: CHEBI:45652


subject: CHEBI:45652


subject: CHEBI:45652


subject: CHEBI:5123

subject_name: Fluphenazine

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Ascites


subject: PUBCHEM.COMPOUND:46783403

object_name: Ascites, CTCAE


subject: UNII:9VR1J6U4XG

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C0003240

subject_name: Macrolide Antibiotics

object_name: bronchiectasis


subject: CHEBI:25106

subject_name: macrolide


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Burn, CTCAE


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: age-related macular degeneration


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: metastatic neoplasm


subject: PR:000001379

object_name: Childhood Solid Neoplasm


subject: PR:000001379

object_name: Adult Solid Neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: Neoplasm Metastasis


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907


subject: PUBCHEM.COMPOUND:146014907

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:146014907


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: UMLS:C4329606

subject_name: CTAG1 Antibody


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UniProtKB:P78358

subject_name: CTG1B_HUMAN Cancer/testis antigen 1 (sprot)


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C4684969

subject_name: Trimeric GITRL-Fc OMP-336B11

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4684969


subject: UMLS:C4684969


subject: UMLS:C4684969

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:40799

subject_name: Boldione

object_name: Depressed mood


subject: CHEBI:40799

object_name: Cancer patients and suicide and depression


subject: CHEBI:40799

object_name: Depressed - symptom


subject: CHEBI:40799

object_name: Depression, CTCAE


subject: CHEBI:40799

object_name: mood disorder


subject: CHEBI:40799

object_name: mental disorder


subject: CHEBI:40799

object_name: psychiatric disorder


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:135542222

subject_name: Isoniazid & Rifapentine

object_name: silicosis; with tuberculosis


subject: UMLS:C3896923

subject_name: Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3896923

object_name: clear cell renal carcinoma


subject: UMLS:C3896923

object_name: renal cell adenocarcinoma


subject: UMLS:C3896923

object_name: renal cell carcinoma


subject: CHEBI:63631

subject_name: Topiramate

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:63631

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:6801

subject_name: Metformin

object_name: Li-Fraumeni syndrome


subject: UMLS:C4287707

subject_name: Cdk4/6 inhibitor shr6390

object_name: Childhood Breast Carcinoma


subject: UMLS:C4287707

object_name: breast carcinoma


subject: UMLS:C4287707

object_name: breast cancer


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Refractory Lymphoma


subject: CHEBI:79699

object_name: Recurrent Lymphoma


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: UMLS:C5417997

subject_name: BTK Inhibitor SAR442168

object_name: multiple sclerosis


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: metabolic disease


subject: CHEBI:35366

subject_name: fatty acid

object_name: coronary artery disorder


subject: CHEBI:35366

object_name: myocardial ischemia


subject: CHEBI:35366

object_name: coronary atherosclerosis


subject: CHEBI:35366

object_name: heart disorder


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Advanced Esophageal Squamous Cell Carcinoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic urothelial carcinoma


subject: UMLS:C3896806


subject: CHEBI:4875

subject_name: Etanercept

object_name: Recurrence


subject: CHEBI:4875

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:4875

object_name: Recurrent disease


subject: CHEBI:4875

object_name: Recurrent tumor


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: CHEBI:88249

subject_name: Mirdametinib

object_name: plexiform neurofibroma


subject: UMLS:C1675748

object_name: neurofibromatosis 1


subject: UMLS:C1675748


subject: UMLS:C5544340

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C5785368

subject_name: KRAS G12D Inhibitor HRS-4642

object_name: pancreatic neoplasm


subject: UMLS:C5785368

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5785368

object_name: malignant pancreatic neoplasm


subject: CHEBI:73757

subject_name: Ala-Gly


subject: CHEBI:73757


subject: CHEBI:73757


subject: CHEBI:193565


subject: CHEBI:193565


subject: CHEBI:193565


subject: CHEBI:73836

subject_name: D-Ala-Gly


subject: CHEBI:73836


subject: CHEBI:73836


subject: UMLS:C1370189

subject_name: Pneumocystis jiroveci antigen


subject: UMLS:C1370189


subject: UMLS:C1370189


subject: CHEBI:27569

subject_name: arabinogalactan


subject: CHEBI:27569


subject: CHEBI:27569


subject: MESH:D019081

subject_name: O Antigens


subject: MESH:D019081


subject: MESH:D019081


subject: MESH:D000941

subject_name: Antigens


subject: MESH:D000941


subject: MESH:D000941


subject: UMLS:C0808086

subject_name: Streptococcus pneumoniae group B Antigen


subject: UMLS:C0808086


subject: UMLS:C0808086


subject: UMLS:C0808084

subject_name: Streptococcus pneumoniae group A Antigen


subject: UMLS:C0808084


subject: UMLS:C0808084


subject: UMLS:C1545907

subject_name: A variant not otherwise specified Antigen


subject: UMLS:C1545907


subject: UMLS:C1545907


subject: CHEBI:2654

subject_name: Aminoglutethimide


subject: CHEBI:2654


subject: CHEBI:2654


subject: CHEBI:30512

subject_name: Silver


subject: CHEBI:30512


subject: CHEBI:30512


subject: CHEBI:49468

subject_name: Silver cation


subject: CHEBI:49468


subject: CHEBI:49468


subject: CHEBI:40618

subject_name: Pimagedine


subject: CHEBI:40618


subject: CHEBI:40618


subject: PR:000004168

subject_name: amyloid-beta precursor protein


subject: PR:000004168


subject: PR:000004168


subject: UMLS:C0243192

subject_name: agonists


subject: UMLS:C0243192


subject: UMLS:C0243192


subject: UNII:UG97LO5M8Y

subject_name: Tesetaxel

object_name: Carcinoma breast stage IV


subject: UMLS:C0879469

object_name: ovarian cancer


subject: UMLS:C0879469

object_name: ovarian neoplasm


subject: UMLS:C0879469

object_name: ovarian carcinoma


subject: UMLS:C0879469

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0879469

object_name: Embolism, Tumor


subject: UMLS:C0879469

object_name: Neoplasm Metastasis


subject: UMLS:C0879469

object_name: fallopian tube carcinoma


subject: UMLS:C0879469

object_name: fallopian tube cancer


subject: UMLS:C0879469

object_name: peritoneum cancer


subject: CHEBI:4672

subject_name: Docetaxel

object_name: stage IIA non-small cell lung cancer


subject: CHEBI:4672

object_name: stage IB non-small cell lung cancer


subject: CHEBI:4672

object_name: stage IIB non-small cell lung cancer


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:31617


subject: CHEBI:31617

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:31617


subject: CHEBI:31617

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:31617


subject: CHEBI:177762

subject_name: Alovudine

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:177762

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:177762


subject: CHEBI:177762


subject: CHEBI:177762


subject: CHEBI:177762


subject: CHEBI:177762


subject: CHEBI:177762


subject: CHEBI:177762

object_name: Non-small cell lung cancer recurrent


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: PR:000007563


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: Surgical procedure finding


subject: CHEBI:17925

object_name: Non-diabetic hyperglycemia


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: UMLS:C3714501

subject_name: Insulin Drug Class


subject: UMLS:C3714501


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: MESH:C541234

subject_name: diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine

object_name: meningococcal meningitis


subject: UMLS:C0065828

subject_name: Measles-Mumps-Rubella Vaccine


subject: PR:000002972

subject_name: macrophage mannose receptor 1


subject: PR:000012439

subject_name: proprotein convertase subtilisin/kexin type 7


subject: MESH:D019433

subject_name: Chickenpox Vaccine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Genitourinary Cancer


subject: UNII:52CMI0WC3Y

object_name: female reproductive organ cancer


subject: UNII:52CMI0WC3Y

object_name: Unknown Primary Tumors


subject: UNII:52CMI0WC3Y

object_name: skin neoplasm


subject: UNII:52CMI0WC3Y

object_name: skin cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hemorrhage


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEMBL.COMPOUND:CHEMBL2109509

object_name: neoplasm


subject: UMLS:C1541533

subject_name: monoclonal antibody CBE-11


subject: UMLS:C0762110

object_name: Cirrhosis


subject: UMLS:C0762110

object_name: liver cirrhosis


subject: CHEBI:17925

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:17925

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:24749


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:35469

subject_name: antidepressant

object_name: Chronic low back pain


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: CHEBI:92998

subject_name: Guanabenz

object_name: Surgical Adhesions


subject: CHEBI:5931

object_name: coronary microvascular disorder


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: pain agnosia


subject: CHEBI:50731

object_name: Pain insensitivity


subject: UMLS:C1620460

subject_name: DepoDur


subject: UMLS:C1620460


subject: UMLS:C2986409

subject_name: BRAF Inhibitor ARQ 736

object_name: Childhood Solid Neoplasm


subject: UMLS:C2986409

object_name: Adult Solid Neoplasm


subject: UMLS:C2986409

object_name: Solid Neoplasm


subject: CHEBI:52172

subject_name: Nilotinib

object_name: graft versus host disease


subject: UNII:OLF97F86A7

subject_name: Galidesivir


subject: UNII:OLF97F86A7

object_name: yellow fever


subject: CHEBI:29108

subject_name: Calcium cation

object_name: thyroid disease


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C1337396

subject_name: minocycline HCl microspheres

object_name: Peri-Implantitis


subject: CHEBI:63589

subject_name: Etravirine

object_name: hepatitis C


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: prostate carcinoma


subject: CHEBI:4636

object_name: prostate cancer


subject: UMLS:C1518042

subject_name: DOTA-HUJ-591 LU-177

object_name: metastatic prostate carcinoma


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: Refractory Indolent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:71226663

object_name: Follicular lymphoma refractory


subject: PUBCHEM.COMPOUND:71226663

object_name: Marginal zone lymphoma refractory


subject: PUBCHEM.COMPOUND:71226663

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: PUBCHEM.COMPOUND:71226663

object_name: Splenic marginal zone lymphoma refractory


subject: PUBCHEM.COMPOUND:71226663

object_name: Follicular lymphoma recurrent


subject: PUBCHEM.COMPOUND:71226663

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:71226663

object_name: Nodal marginal zone B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:71226663

object_name: Splenic marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: PUBCHEM.COMPOUND:58008990


subject: UNII:VM4G5D1A60

subject_name: LADIRATUZUMAB VEDOTIN

object_name: triple-negative breast carcinoma


subject: UMLS:C3827076


subject: RXCUI:1790637

subject_name: formoterol / glycopyrronium Metered Dose Inhaler

object_name: chronic obstructive pulmonary disease


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Blood Pressure Finding


subject: CHEBI:46195

object_name: Systemic arterial pressure


subject: UNII:0Q42P4YI6B

object_name: malaria


subject: UMLS:C4329321

object_name: Neck Carcinoma


subject: UMLS:C4329321

object_name: head and neck neoplasm


subject: UMLS:C4329321

object_name: head and neck cancer


subject: DRUGBANK:DB18231

object_name: Adult Solid Neoplasm


subject: UMLS:C5434105

subject_name: Injection, sacituzumab govitecan-hziy, 2.5 mg


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: prostate carcinoma


subject: CHEBI:131701

object_name: prostate cancer


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Complication of transplanted lung


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:135402036


subject: PUBCHEM.COMPOUND:135402036


subject: CHEBI:17202

subject_name: Inosinic Acid


subject: CHEBI:17202


subject: CHEBI:58053


subject: CHEBI:58053


subject: CHEBI:190509

subject_name: Imipenem


subject: CHEBI:190509


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Knee arthropathy


subject: CHEBI:9398

object_name: Hip arthropathy


subject: UMLS:C4053604

subject_name: Phosphaplatin PT-112

object_name: Thymoma malignant recurrent


subject: UMLS:C4053604

object_name: thymus cancer


subject: UMLS:C4053604

object_name: thymic epithelial neoplasm


subject: CHEBI:51817

subject_name: Temocillin

object_name: Sepsis


subject: CHEBI:51817

object_name: Sepsis, CTCAE


subject: CHEBI:51817

object_name: septic shock


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Sicca Syndrome


subject: CHEBI:5801

object_name: Xerostomia


subject: CHEBI:37845

subject_name: growth hormone

object_name: chronic childhood arthritis


subject: CHEBI:37845

object_name: juvenile idiopathic arthritis


subject: CHEBI:37845

object_name: HIV infection


subject: CHEBI:37845

object_name: cerebral palsy


subject: CHEBI:37845

object_name: inflammatory bowel disease 1


subject: CHEBI:37845

object_name: Crohn disease


subject: CHEBI:37845

object_name: mucopolysaccharidosis type 1


subject: CHEBI:37845

object_name: Hurler syndrome


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: PR:000007968


subject: UMLS:C5226606

object_name: osteoporosis


subject: UMLS:C5226606

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C5226606

object_name: Osteoporosis, CTCAE 5.0